KX2-361 is an orally administered small molecule that concurrently inhibits Src kinase and tubulin polymerization. This dual-action inhibitor has demonstrated efficacy in preclinical glioblastoma research, significantly extending survival in murine models and showing potent anti-proliferative activity in vitro against cancer cell lines.
Molekulargewicht:
405.46
Reinheit:
99.86% (May vary between batches)
CAS Nummer:
[897016-26-1]
Formel:
C24H24FN3O2
Target-Kategorie:
Apoptosis,Src,Microtubule Associated
Anwendungsbeschreibung:
Solubility: DMSO:8.75 mg/mL (21.58 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten